|
CTLT
|
Catalent, Inc.
|
US
|
NYSE
|
|
CUE
|
Cue Biopharma, Inc.
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
US
|
NASDAQ
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
CYCN
|
Cyclerion Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DICE
|
DICE Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DMAC
|
DiaMedica Therapeutics Inc.
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
|
DVAX
|
Dynavax Technologies Corporation
|
US
|
NASDAQ
|
|
DYAI
|
Dyadic International, Inc.
|
US
|
NASDAQ
|
|
EDSA
|
Edesa Biotech, Inc.
|
US
|
NASDAQ
|
|
EFTR
|
eFFECTOR Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ELEV
|
Elevation Oncology, Inc.
|
US
|
NASDAQ
|
|
ELOX
|
Eloxx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ENTX
|
Entera Bio Ltd.
|
US
|
NASDAQ
|